Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Negative Regulation Of Epithelial To Mesenchymal Transition (GO:0010719),0.0013499203983962495,27.596385542168676,182.34890311892423,"['SPRED2', 'SPRED1', 'SFRP2']",0.17907858389467976,0,0,3
2,Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),0.00259605092625245,18.3855421686747,109.46317656794913,"['SPRED2', 'SPRED1', 'SFRP2']",0.17907858389467976,0,0,3
3,Negative Regulation Of Smooth Muscle Cell Differentiation (GO:0051151),0.0028043626113260813,inf,inf,"['NFATC2', 'FOXO4']",0.17907858389467976,0,0,2
4,Inositol Phosphate-Mediated Signaling (GO:0048016),0.0028043626113260813,inf,inf,"['NFATC2', 'NMUR2']",0.17907858389467976,0,0,2
5,Regulation Of Protein Deacetylation (GO:0090311),0.0028043626113260813,inf,inf,"['SPRED2', 'SPRED1']",0.17907858389467976,0,0,2
6,Regulation Of Systemic Arterial Blood Pressure By Hormone (GO:0001990),0.0028043626113260813,inf,inf,"['ENPEP', 'RASL10B']",0.17907858389467976,0,0,2
7,"Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043516)",0.0028043626113260813,inf,inf,"['SPRED2', 'SPRED1']",0.17907858389467976,0,0,2
8,Negative Regulation Of Epithelial Cell Differentiation (GO:0030857),0.008121042480496608,36.38095238095238,175.11231981172114,"['SPRED2', 'SPRED1']",0.22669522238858958,0,0,2
9,Negative Regulation Of Lens Fiber Cell Differentiation (GO:1902747),0.008121042480496608,36.38095238095238,175.11231981172114,"['SPRED2', 'SPRED1']",0.22669522238858958,0,0,2
10,Regulation Of Lens Fiber Cell Differentiation (GO:1902746),0.008121042480496608,36.38095238095238,175.11231981172114,"['SPRED2', 'SPRED1']",0.22669522238858958,0,0,2
11,Regulation Of Cardiac Muscle Hypertrophy (GO:0010611),0.008121042480496608,36.38095238095238,175.11231981172114,"['NR4A3', 'LMCD1']",0.22669522238858958,0,0,2
12,"Positive Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043517)",0.015680510978337565,18.178571428571427,75.5380845869112,"['SPRED2', 'SPRED1']",0.22669522238858958,0,0,2
13,Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),0.015716767055533876,4.923577235772358,20.44775003954874,"['FGF17', 'NR4A3', 'UBASH3B', 'FOXO4']",0.22669522238858958,0,0,4
14,Regulation Of Angiogenesis (GO:0045765),0.01886281208403689,4.612804878048781,18.315431958991134,"['SPRED1', 'SFRP2', 'ADAMTS1', 'FOXO4']",0.22669522238858958,0,0,4
15,Regulation Of Protein Modification Process (GO:0031399),0.02523426690355913,12.11111111111111,44.56346808141656,"['SPRED2', 'SPRED1']",0.22669522238858958,0,0,2
16,Protein Localization To Plasma Membrane (GO:0072659),0.02523426690355913,12.11111111111111,44.56346808141656,"['TRARG1', 'PLEKHF1']",0.22669522238858958,0,0,2
17,Cellular Response To Insulin Stimulus (GO:0032869),0.02523426690355913,12.11111111111111,44.56346808141656,"['TRARG1', 'FOXO4']",0.22669522238858958,0,0,2
18,Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),0.02523426690355913,12.11111111111111,44.56346808141656,"['SPRED1', 'FOXO4']",0.22669522238858958,0,0,2
19,Negative Regulation Of Cell Differentiation (GO:0045596),0.034644269199663555,4.9879518072289155,16.77260126082416,"['SPRED2', 'SPRED1', 'SFRP2']",0.22669522238858958,0,0,3
20,Negative Regulation Of Protein Phosphorylation (GO:0001933),0.035181075604510656,3.680487804878049,12.31950163762297,"['SPRED2', 'SPRED1', 'SFRP2', 'UBASH3B']",0.22669522238858958,0,0,4
21,Negative Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010801),0.03655340151145647,9.077380952380953,30.036881396274886,"['SPRED2', 'SPRED1']",0.22669522238858958,0,0,2
22,Protein Localization To Cell Periphery (GO:1990778),0.03655340151145647,9.077380952380953,30.036881396274886,"['TRARG1', 'PLEKHF1']",0.22669522238858958,0,0,2
23,Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),0.03655340151145647,9.077380952380953,30.036881396274886,"['SPRED2', 'SPRED1']",0.22669522238858958,0,0,2
24,Negative Regulation Of Angiogenesis (GO:0016525),0.03655340151145647,9.077380952380953,30.036881396274886,"['SPRED1', 'FOXO4']",0.22669522238858958,0,0,2
25,Proteolysis (GO:0006508),0.045664207685545896,3.341463414634146,10.313227977356357,"['COLEC11', 'ENPEP', 'CYP2A6', 'ADAMTS1']",0.22669522238858958,0,0,4
26,Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010799),0.049427254728420175,7.257142857142857,21.82406674603809,"['SPRED2', 'SPRED1']",0.22669522238858958,0,0,2
27,Cellular Response To Peptide Hormone Stimulus (GO:0071375),0.049427254728420175,7.257142857142857,21.82406674603809,"['TRARG1', 'NR4A3']",0.22669522238858958,0,0,2
28,Somite Development (GO:0061053),0.05325055559463514,inf,inf,['SFRP2'],0.22669522238858958,0,0,1
29,Regulation Of Cellular Senescence (GO:2000772),0.05325055559463514,inf,inf,['YPEL3'],0.22669522238858958,0,0,1
30,Positive Regulation Of Hippo Signaling (GO:0035332),0.05325055559463514,inf,inf,['FRMD6'],0.22669522238858958,0,0,1
31,B Cell Receptor Signaling Pathway (GO:0050853),0.05325055559463514,inf,inf,['NFATC2'],0.22669522238858958,0,0,1
32,Regulation Of Cilium Assembly (GO:1902017),0.05325055559463514,inf,inf,['TBC1D10C'],0.22669522238858958,0,0,1
33,Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),0.05325055559463514,inf,inf,['PSG4'],0.22669522238858958,0,0,1
34,Fatty Acid Alpha-Oxidation (GO:0001561),0.05325055559463514,inf,inf,['HAO2'],0.22669522238858958,0,0,1
35,Fc Receptor Mediated Stimulatory Signaling Pathway (GO:0002431),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
36,Fc-epsilon Receptor Signaling Pathway (GO:0038095),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
37,G Protein-Coupled Glutamate Receptor Signaling Pathway (GO:0007216),0.05325055559463514,inf,inf,['HOMER1'],0.22669522238858958,0,0,1
38,fatty-acyl-CoA Metabolic Process (GO:0035337),0.05325055559463514,inf,inf,['THEM5'],0.22669522238858958,0,0,1
39,Filopodium Assembly (GO:0046847),0.05325055559463514,inf,inf,['MRAP'],0.22669522238858958,0,0,1
40,Negative Regulation Of mRNA Catabolic Process (GO:1902373),0.05325055559463514,inf,inf,['DND1'],0.22669522238858958,0,0,1
41,Positive Regulation Of Mast Cell Activation (GO:0033005),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
42,Regulation Of Fatty Acid Oxidation (GO:0046320),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
43,Glomerular Epithelial Cell Development (GO:0072310),0.05325055559463514,inf,inf,['MYO1E'],0.22669522238858958,0,0,1
44,Glomerular Filtration (GO:0003094),0.05325055559463514,inf,inf,['MYO1E'],0.22669522238858958,0,0,1
45,Negative Regulation Of Muscle Cell Differentiation (GO:0051148),0.05325055559463514,inf,inf,['FOXO4'],0.22669522238858958,0,0,1
46,Glucose Import (GO:0046323),0.05325055559463514,inf,inf,['TRARG1'],0.22669522238858958,0,0,1
47,Regulation Of Glucose Transmembrane Transport (GO:0010827),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
48,Positive Regulation Of Muscle Hypertrophy (GO:0014742),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
49,Positive Regulation Of Myeloid Leukocyte Cytokine Production Involved In Immune Response (GO:0061081),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
50,RNA Stabilization (GO:0043489),0.05325055559463514,inf,inf,['DND1'],0.22669522238858958,0,0,1
51,Regulation Of Hippo Signaling (GO:0035330),0.05325055559463514,inf,inf,['FRMD6'],0.22669522238858958,0,0,1
52,Positive Regulation Of Opsonization (GO:1903028),0.05325055559463514,inf,inf,['COLEC11'],0.22669522238858958,0,0,1
53,Vesicle Transport Along Actin Filament (GO:0030050),0.05325055559463514,inf,inf,['MYO1E'],0.22669522238858958,0,0,1
54,Heterocycle Catabolic Process (GO:0046700),0.05325055559463514,inf,inf,['CYP2A6'],0.22669522238858958,0,0,1
55,Actin Filament-Based Transport (GO:0099515),0.05325055559463514,inf,inf,['MYO1E'],0.22669522238858958,0,0,1
56,Activation Of GTPase Activity (GO:0090630),0.05325055559463514,inf,inf,['TBC1D10C'],0.22669522238858958,0,0,1
57,Adenylate Cyclase-Inhibiting G Protein-Coupled Acetylcholine Receptor Signaling Pathway (GO:0007197),0.05325055559463514,inf,inf,['CHRM5'],0.22669522238858958,0,0,1
58,Immune Response-Inhibiting Cell Surface Receptor Signaling Pathway (GO:0002767),0.05325055559463514,inf,inf,['PSG4'],0.22669522238858958,0,0,1
59,Import Into Cell (GO:0098657),0.05325055559463514,inf,inf,['SLC5A3'],0.22669522238858958,0,0,1
60,Positive Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903428),0.05325055559463514,inf,inf,['SLC5A3'],0.22669522238858958,0,0,1
61,Inositol Metabolic Process (GO:0006020),0.05325055559463514,inf,inf,['SLC5A3'],0.22669522238858958,0,0,1
62,Insulin Receptor Signaling Pathway (GO:0008286),0.05325055559463514,inf,inf,['FOXO4'],0.22669522238858958,0,0,1
63,Negative Regulation Of Vascular Associated Smooth Muscle Cell Differentiation (GO:1905064),0.05325055559463514,inf,inf,['NFATC2'],0.22669522238858958,0,0,1
64,Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),0.05325055559463514,inf,inf,['RAET1E'],0.22669522238858958,0,0,1
65,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway (GO:0002484),0.05325055559463514,inf,inf,['RAET1E'],0.22669522238858958,0,0,1
66,"Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent (GO:0002486)",0.05325055559463514,inf,inf,['RAET1E'],0.22669522238858958,0,0,1
67,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class Ib (GO:0002476),0.05325055559463514,inf,inf,['RAET1E'],0.22669522238858958,0,0,1
68,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class Ib (GO:0002428),0.05325055559463514,inf,inf,['RAET1E'],0.22669522238858958,0,0,1
69,Regulation Of Opsonization (GO:1903027),0.05325055559463514,inf,inf,['COLEC11'],0.22669522238858958,0,0,1
70,Lipid Oxidation (GO:0034440),0.05325055559463514,inf,inf,['HAO2'],0.22669522238858958,0,0,1
71,Branching Involved In Blood Vessel Morphogenesis (GO:0001569),0.05325055559463514,inf,inf,['SFRP2'],0.22669522238858958,0,0,1
72,Regulation Of Plasma Membrane Bounded Cell Projection Organization (GO:0120035),0.05325055559463514,inf,inf,['HOMER1'],0.22669522238858958,0,0,1
73,Primary Alcohol Metabolic Process (GO:0034308),0.05325055559463514,inf,inf,['HSD11B2'],0.22669522238858958,0,0,1
74,calcineurin-NFAT Signaling Cascade (GO:0033173),0.05325055559463514,inf,inf,['NFATC2'],0.22669522238858958,0,0,1
75,Calcineurin-Mediated Signaling (GO:0097720),0.05325055559463514,inf,inf,['NFATC2'],0.22669522238858958,0,0,1
76,Prostaglandin Biosynthetic Process (GO:0001516),0.05325055559463514,inf,inf,['PTGES'],0.22669522238858958,0,0,1
77,Prostanoid Biosynthetic Process (GO:0046457),0.05325055559463514,inf,inf,['PTGES'],0.22669522238858958,0,0,1
78,Cardiac Left Ventricle Morphogenesis (GO:0003214),0.05325055559463514,inf,inf,['SFRP2'],0.22669522238858958,0,0,1
79,Cardiolipin Acyl-Chain Remodeling (GO:0035965),0.05325055559463514,inf,inf,['THEM5'],0.22669522238858958,0,0,1
80,Cardiolipin Metabolic Process (GO:0032048),0.05325055559463514,inf,inf,['THEM5'],0.22669522238858958,0,0,1
81,Cell Projection Assembly (GO:0030031),0.05325055559463514,inf,inf,['NEFH'],0.22669522238858958,0,0,1
82,Cell Surface Pattern Recognition Receptor Signaling Pathway (GO:0002752),0.05325055559463514,inf,inf,['COLEC11'],0.22669522238858958,0,0,1
83,Regulation Of Smooth Muscle Cell Differentiation (GO:0051150),0.05325055559463514,inf,inf,['FOXO4'],0.22669522238858958,0,0,1
84,Regulation Of Systemic Arterial Blood Pressure By Renin-Angiotensin (GO:0003081),0.05325055559463514,inf,inf,['ENPEP'],0.22669522238858958,0,0,1
85,Platelet-Derived Growth Factor Receptor Signaling Pathway (GO:0048008),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
86,Podocyte Development (GO:0072015),0.05325055559463514,inf,inf,['MYO1E'],0.22669522238858958,0,0,1
87,Podocyte Differentiation (GO:0072112),0.05325055559463514,inf,inf,['MYO1E'],0.22669522238858958,0,0,1
88,Polyol Metabolic Process (GO:0019751),0.05325055559463514,inf,inf,['SLC5A3'],0.22669522238858958,0,0,1
89,Cellular Response To Monoamine Stimulus (GO:0071868),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
90,Regulation Of Vascular Associated Smooth Muscle Cell Differentiation (GO:1905063),0.05325055559463514,inf,inf,['NFATC2'],0.22669522238858958,0,0,1
91,Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),0.05325055559463514,inf,inf,['RAET1E'],0.22669522238858958,0,0,1
92,Positive Regulation Of T Cell Mediated Immunity (GO:0002711),0.05325055559463514,inf,inf,['RAET1E'],0.22669522238858958,0,0,1
93,Renal Filtration (GO:0097205),0.05325055559463514,inf,inf,['MYO1E'],0.22669522238858958,0,0,1
94,Myelination (GO:0042552),0.05325055559463514,inf,inf,['MALL'],0.22669522238858958,0,0,1
95,Regulation Of G0 To G1 Transition (GO:0070316),0.05325055559463514,inf,inf,['FOXO4'],0.22669522238858958,0,0,1
96,Collagen-Activated Signaling Pathway (GO:0038065),0.05325055559463514,inf,inf,['UBASH3B'],0.22669522238858958,0,0,1
97,Response To Catecholamine (GO:0071869),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
98,Coronary Vasculature Morphogenesis (GO:0060977),0.05325055559463514,inf,inf,['SPRED1'],0.22669522238858958,0,0,1
99,Coumarin Metabolic Process (GO:0009804),0.05325055559463514,inf,inf,['CYP2A6'],0.22669522238858958,0,0,1
100,Positive Regulation Of calcineurin-NFAT Signaling Cascade (GO:0070886),0.05325055559463514,inf,inf,['LMCD1'],0.22669522238858958,0,0,1
101,Positive Regulation Of Calcineurin-Mediated Signaling (GO:0106058),0.05325055559463514,inf,inf,['LMCD1'],0.22669522238858958,0,0,1
102,Positive Regulation Of Cardiac Muscle Hypertrophy (GO:0010613),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
103,Positive Regulation Of Cellular Senescence (GO:2000774),0.05325055559463514,inf,inf,['YPEL3'],0.22669522238858958,0,0,1
104,Negative Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900016),0.05325055559463514,inf,inf,['PSG4'],0.22669522238858958,0,0,1
105,Positive Regulation Of Fatty Acid Metabolic Process (GO:0045923),0.05325055559463514,inf,inf,['NR4A3'],0.22669522238858958,0,0,1
106,Positive Regulation Of Signal Transduction By P53 Class Mediator (GO:1901798),0.06366215634955497,6.0436507936507935,16.645211396172666,"['SPRED2', 'SPRED1']",0.25609109083418924,0,0,2
107,Protein Localization To Membrane (GO:0072657),0.06366215634955497,6.0436507936507935,16.645211396172666,"['TRARG1', 'PLEKHF1']",0.25609109083418924,0,0,2
108,Negative Regulation Of Multicellular Organismal Process (GO:0051241),0.076211969713375,3.417921686746988,8.798539600198753,"['SPRED2', 'SPRED1', 'SFRP2']",0.25609109083418924,0,0,3
109,Steroid Metabolic Process (GO:0008202),0.07908024705704403,5.1768707482993195,13.135233545101583,"['HSD11B2', 'CYP2A6']",0.25609109083418924,0,0,2
110,Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),0.07908024705704403,5.1768707482993195,13.135233545101583,"['SPRED2', 'SPRED1']",0.25609109083418924,0,0,2
111,Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),0.09551837464646203,4.526785714285714,10.630869456975239,"['SPRED2', 'SPRED1']",0.25609109083418924,0,0,2
112,3'-UTR-mediated mRNA Destabilization (GO:0061158),0.1036968399127254,17.976470588235294,40.739781155366295,['DND1'],0.25609109083418924,0,0,1
113,Positive Regulation Of Glucose Transmembrane Transport (GO:0010828),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
114,Epoxygenase P450 Pathway (GO:0019373),0.1036968399127254,17.976470588235294,40.739781155366295,['CYP2A6'],0.25609109083418924,0,0,1
115,Negative Regulation Of Execution Phase Of Apoptosis (GO:1900118),0.1036968399127254,17.976470588235294,40.739781155366295,['MTRNR2L8'],0.25609109083418924,0,0,1
116,Positive Regulation Of Hormone Secretion (GO:0046887),0.1036968399127254,17.976470588235294,40.739781155366295,['RASL10B'],0.25609109083418924,0,0,1
117,Establishment Of Protein Localization To Plasma Membrane (GO:0061951),0.1036968399127254,17.976470588235294,40.739781155366295,['TRARG1'],0.25609109083418924,0,0,1
118,Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),0.1036968399127254,17.976470588235294,40.739781155366295,['RAET1E'],0.25609109083418924,0,0,1
119,Fatty Acid Oxidation (GO:0019395),0.1036968399127254,17.976470588235294,40.739781155366295,['HAO2'],0.25609109083418924,0,0,1
120,Gastrulation (GO:0007369),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
121,Glucocorticoid Metabolic Process (GO:0008211),0.1036968399127254,17.976470588235294,40.739781155366295,['HSD11B2'],0.25609109083418924,0,0,1
122,Glucose Transmembrane Transport (GO:1904659),0.1036968399127254,17.976470588235294,40.739781155366295,['SLC5A3'],0.25609109083418924,0,0,1
123,Glutamate Receptor Signaling Pathway (GO:0007215),0.1036968399127254,17.976470588235294,40.739781155366295,['HOMER1'],0.25609109083418924,0,0,1
124,Positive Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045954),0.1036968399127254,17.976470588235294,40.739781155366295,['RAET1E'],0.25609109083418924,0,0,1
125,Positive Regulation Of Natural Killer Cell Mediated Immunity (GO:0002717),0.1036968399127254,17.976470588235294,40.739781155366295,['RAET1E'],0.25609109083418924,0,0,1
126,Vasculogenesis (GO:0001570),0.1036968399127254,17.976470588235294,40.739781155366295,['SPRED1'],0.25609109083418924,0,0,1
127,Hematopoietic Stem Cell Proliferation (GO:0071425),0.1036968399127254,17.976470588235294,40.739781155366295,['SFRP2'],0.25609109083418924,0,0,1
128,Positive Regulation Of Peptide Secretion (GO:0002793),0.1036968399127254,17.976470588235294,40.739781155366295,['RASL10B'],0.25609109083418924,0,0,1
129,Vesicle Cytoskeletal Trafficking (GO:0099518),0.1036968399127254,17.976470588235294,40.739781155366295,['MYO1E'],0.25609109083418924,0,0,1
130,Regulation Of Intracellular Transport (GO:0032386),0.1036968399127254,17.976470588235294,40.739781155366295,['NEFH'],0.25609109083418924,0,0,1
131,Hexose Transmembrane Transport (GO:0008645),0.1036968399127254,17.976470588235294,40.739781155366295,['SLC5A3'],0.25609109083418924,0,0,1
132,Xenobiotic Catabolic Process (GO:0042178),0.1036968399127254,17.976470588235294,40.739781155366295,['CYP2A6'],0.25609109083418924,0,0,1
133,Negative Regulation Of Signaling (GO:0023057),0.1036968399127254,17.976470588235294,40.739781155366295,['UBASH3B'],0.25609109083418924,0,0,1
134,Regulation Of mRNA Stability (GO:0043488),0.1036968399127254,17.976470588235294,40.739781155366295,['DND1'],0.25609109083418924,0,0,1
135,Icosanoid Secretion (GO:0032309),0.1036968399127254,17.976470588235294,40.739781155366295,['NMUR2'],0.25609109083418924,0,0,1
136,Innate Immune Response Activating Cell Surface Receptor Signaling Pathway (GO:0002220),0.1036968399127254,17.976470588235294,40.739781155366295,['COLEC11'],0.25609109083418924,0,0,1
137,Regulation Of miRNA-mediated Gene Silencing (GO:0060964),0.1036968399127254,17.976470588235294,40.739781155366295,['DND1'],0.25609109083418924,0,0,1
138,Regulation Of Microtubule-Based Movement (GO:0060632),0.1036968399127254,17.976470588235294,40.739781155366295,['NEFH'],0.25609109083418924,0,0,1
139,Positive Regulation Of Signaling (GO:0023056),0.1036968399127254,17.976470588235294,40.739781155366295,['HOMER1'],0.25609109083418924,0,0,1
140,Positive Regulation Of Smooth Muscle Cell Migration (GO:0014911),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
141,Regulation Of Muscle Contraction (GO:0006937),0.1036968399127254,17.976470588235294,40.739781155366295,['NMUR2'],0.25609109083418924,0,0,1
142,Arachidonate Transport (GO:1903963),0.1036968399127254,17.976470588235294,40.739781155366295,['NMUR2'],0.25609109083418924,0,0,1
143,Arachidonic Acid Secretion (GO:0050482),0.1036968399127254,17.976470588235294,40.739781155366295,['NMUR2'],0.25609109083418924,0,0,1
144,Regulation Of Myeloid Leukocyte Differentiation (GO:0002761),0.1036968399127254,17.976470588235294,40.739781155366295,['UBASH3B'],0.25609109083418924,0,0,1
145,Positive Regulation Of Transmembrane Transport (GO:0034764),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
146,Positive Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904754),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
147,Long-Chain fatty-acyl-CoA Metabolic Process (GO:0035336),0.1036968399127254,17.976470588235294,40.739781155366295,['THEM5'],0.25609109083418924,0,0,1
148,Prostaglandin Metabolic Process (GO:0006693),0.1036968399127254,17.976470588235294,40.739781155366295,['PTGES'],0.25609109083418924,0,0,1
149,Prostanoid Metabolic Process (GO:0006692),0.1036968399127254,17.976470588235294,40.739781155366295,['PTGES'],0.25609109083418924,0,0,1
150,Calcium-Independent Cell-Cell Adhesion Via Plasma Membrane Cell-Adhesion Molecules (GO:0016338),0.1036968399127254,17.976470588235294,40.739781155366295,['CLDN9'],0.25609109083418924,0,0,1
151,mRNA Destabilization (GO:0061157),0.1036968399127254,17.976470588235294,40.739781155366295,['DND1'],0.25609109083418924,0,0,1
152,mRNA Stabilization (GO:0048255),0.1036968399127254,17.976470588235294,40.739781155366295,['DND1'],0.25609109083418924,0,0,1
153,Regulation Of Protein Localization To Membrane (GO:1905475),0.1036968399127254,17.976470588235294,40.739781155366295,['SLC5A3'],0.25609109083418924,0,0,1
154,Peptide Catabolic Process (GO:0043171),0.1036968399127254,17.976470588235294,40.739781155366295,['ENPEP'],0.25609109083418924,0,0,1
155,Mast Cell Activation Involved In Immune Response (GO:0002279),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
156,Mast Cell Degranulation (GO:0043303),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
157,Mast Cell Mediated Immunity (GO:0002448),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
158,Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903426),0.1036968399127254,17.976470588235294,40.739781155366295,['SLC5A3'],0.25609109083418924,0,0,1
159,Regulation Of Regulatory T Cell Differentiation (GO:0045589),0.1036968399127254,17.976470588235294,40.739781155366295,['PSG4'],0.25609109083418924,0,0,1
160,Cell Projection Organization (GO:0030030),0.1036968399127254,17.976470588235294,40.739781155366295,['NEFH'],0.25609109083418924,0,0,1
161,Mesenchyme Development (GO:0060485),0.1036968399127254,17.976470588235294,40.739781155366295,['SFRP2'],0.25609109083418924,0,0,1
162,Regulation Of Smooth Muscle Contraction (GO:0006940),0.1036968399127254,17.976470588235294,40.739781155366295,['NMUR2'],0.25609109083418924,0,0,1
163,Cellular Response To Catecholamine Stimulus (GO:0071870),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
164,Regulation Of Stem Cell Division (GO:2000035),0.1036968399127254,17.976470588235294,40.739781155366295,['SFRP2'],0.25609109083418924,0,0,1
165,Microtubule Depolymerization (GO:0007019),0.1036968399127254,17.976470588235294,40.739781155366295,['STMND1'],0.25609109083418924,0,0,1
166,Regulation Of Store-Operated Calcium Entry (GO:2001256),0.1036968399127254,17.976470588235294,40.739781155366295,['HOMER1'],0.25609109083418924,0,0,1
167,Cellular Response To Leptin Stimulus (GO:0044320),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
168,Regulation Of Type B Pancreatic Cell Proliferation (GO:0061469),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
169,Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904752),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
170,Monosaccharide Transmembrane Transport (GO:0015749),0.1036968399127254,17.976470588235294,40.739781155366295,['SLC5A3'],0.25609109083418924,0,0,1
171,"Complement Activation, Lectin Pathway (GO:0001867)",0.1036968399127254,17.976470588235294,40.739781155366295,['COLEC11'],0.25609109083418924,0,0,1
172,Response To Leptin (GO:0044321),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
173,Positive Regulation Of Cell Adhesion Mediated By Integrin (GO:0033630),0.1036968399127254,17.976470588235294,40.739781155366295,['SFRP2'],0.25609109083418924,0,0,1
174,"Retrograde Transport, Endosome To Golgi (GO:0042147)",0.1036968399127254,17.976470588235294,40.739781155366295,['TBC1D10C'],0.25609109083418924,0,0,1
175,Negative Regulation Of Bone Remodeling (GO:0046851),0.1036968399127254,17.976470588235294,40.739781155366295,['UBASH3B'],0.25609109083418924,0,0,1
176,Negative Regulation Of Bone Resorption (GO:0045779),0.1036968399127254,17.976470588235294,40.739781155366295,['UBASH3B'],0.25609109083418924,0,0,1
177,Regulation Of calcineurin-NFAT Signaling Cascade (GO:0070884),0.1036968399127254,17.976470588235294,40.739781155366295,['LMCD1'],0.25609109083418924,0,0,1
178,Regulation Of Calcium Ion Transmembrane Transport (GO:1903169),0.1036968399127254,17.976470588235294,40.739781155366295,['UBASH3B'],0.25609109083418924,0,0,1
179,Negative Regulation Of Cell Communication (GO:0010648),0.1036968399127254,17.976470588235294,40.739781155366295,['UBASH3B'],0.25609109083418924,0,0,1
180,Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),0.1036968399127254,17.976470588235294,40.739781155366295,['SFRP2'],0.25609109083418924,0,0,1
181,Positive Regulation Of Fatty Acid Oxidation (GO:0046321),0.1036968399127254,17.976470588235294,40.739781155366295,['NR4A3'],0.25609109083418924,0,0,1
182,Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),0.11282706093327467,4.021164021164021,8.773774025224709,"['HOMER1', 'NMUR2']",0.2755939685091463,0,0,2
183,Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),0.11282706093327467,4.021164021164021,8.773774025224709,"['SPRED2', 'SPRED1']",0.2755939685091463,0,0,2
184,Neuron Projection Development (GO:0031175),0.130869534903282,3.6166666666666667,7.354688300509404,"['STMND1', 'NEFH']",0.30364888067548773,0,0,2
185,Supramolecular Fiber Organization (GO:0097435),0.1495208284596289,3.2857142857142856,6.243907175182172,"['MYO1E', 'STMND1']",0.30364888067548773,0,0,2
186,Negative Regulation Of Kinase Activity (GO:0033673),0.1495208284596289,3.2857142857142856,6.243907175182172,"['SPRED1', 'UBASH3B']",0.30364888067548773,0,0,2
187,Negative Regulation Of MAPK Cascade (GO:0043409),0.1495208284596289,3.2857142857142856,6.243907175182172,"['SPRED2', 'SPRED1']",0.30364888067548773,0,0,2
188,Stem Cell Differentiation (GO:0048863),0.15148478834593684,8.98235294117647,16.952125828410935,['FOXO4'],0.30364888067548773,0,0,1
189,Regulation Of Dendritic Spine Maintenance (GO:1902950),0.15148478834593684,8.98235294117647,16.952125828410935,['HOMER1'],0.30364888067548773,0,0,1
190,Positive Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903039),0.15148478834593684,8.98235294117647,16.952125828410935,['NR4A3'],0.30364888067548773,0,0,1
191,Fatty Acid Catabolic Process (GO:0009062),0.15148478834593684,8.98235294117647,16.952125828410935,['HAO2'],0.30364888067548773,0,0,1
192,tRNA 5'-End Processing (GO:0099116),0.15148478834593684,8.98235294117647,16.952125828410935,['RPP25'],0.30364888067548773,0,0,1
193,tRNA 5'-Leader Removal (GO:0001682),0.15148478834593684,8.98235294117647,16.952125828410935,['RPP25'],0.30364888067548773,0,0,1
194,G Protein-Coupled Acetylcholine Receptor Signaling Pathway (GO:0007213),0.15148478834593684,8.98235294117647,16.952125828410935,['CHRM5'],0.30364888067548773,0,0,1
195,Regulation Of Execution Phase Of Apoptosis (GO:1900117),0.15148478834593684,8.98235294117647,16.952125828410935,['MTRNR2L8'],0.30364888067548773,0,0,1
196,Regulation Of Hydrolase Activity (GO:0051336),0.15148478834593684,8.98235294117647,16.952125828410935,['MRAP'],0.30364888067548773,0,0,1
197,Gonad Development (GO:0008406),0.15148478834593684,8.98235294117647,16.952125828410935,['BIK'],0.30364888067548773,0,0,1
198,Acetylcholine Receptor Signaling Pathway (GO:0095500),0.15148478834593684,8.98235294117647,16.952125828410935,['CHRM5'],0.30364888067548773,0,0,1
199,Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:1902229),0.15148478834593684,8.98235294117647,16.952125828410935,['SFRP2'],0.30364888067548773,0,0,1
200,Regulation Of Long-Term Synaptic Potentiation (GO:1900271),0.15148478834593684,8.98235294117647,16.952125828410935,['SCGN'],0.30364888067548773,0,0,1
201,Angiotensin Maturation (GO:0002003),0.15148478834593684,8.98235294117647,16.952125828410935,['ENPEP'],0.30364888067548773,0,0,1
202,Intermediate Filament Bundle Assembly (GO:0045110),0.15148478834593684,8.98235294117647,16.952125828410935,['NEFH'],0.30364888067548773,0,0,1
203,Regulation Of Monoatomic Cation Transmembrane Transport (GO:1904062),0.15148478834593684,8.98235294117647,16.952125828410935,['HOMER1'],0.30364888067548773,0,0,1
204,Arachidonic Acid Metabolic Process (GO:0019369),0.15148478834593684,8.98235294117647,16.952125828410935,['CYP2A6'],0.30364888067548773,0,0,1
205,Non-Canonical Wnt Signaling Pathway (GO:0035567),0.15148478834593684,8.98235294117647,16.952125828410935,['SFRP2'],0.30364888067548773,0,0,1
206,Positive Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904707),0.15148478834593684,8.98235294117647,16.952125828410935,['NR4A3'],0.30364888067548773,0,0,1
207,Regulation Of Organelle Assembly (GO:1902115),0.15148478834593684,8.98235294117647,16.952125828410935,['TBC1D10C'],0.30364888067548773,0,0,1
208,Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),0.15148478834593684,8.98235294117647,16.952125828410935,['TBC1D10C'],0.30364888067548773,0,0,1
209,Pattern Recognition Receptor Signaling Pathway (GO:0002221),0.15148478834593684,8.98235294117647,16.952125828410935,['COLEC11'],0.30364888067548773,0,0,1
210,Male Gonad Development (GO:0008584),0.15148478834593684,8.98235294117647,16.952125828410935,['BIK'],0.30364888067548773,0,0,1
211,Regulation Of Sequestering Of Calcium Ion (GO:0051282),0.15148478834593684,8.98235294117647,16.952125828410935,['UBASH3B'],0.30364888067548773,0,0,1
212,Microtubule Polymerization Or Depolymerization (GO:0031109),0.15148478834593684,8.98235294117647,16.952125828410935,['STMND1'],0.30364888067548773,0,0,1
213,Positive Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:1900087),0.15148478834593684,8.98235294117647,16.952125828410935,['ADAMTS1'],0.30364888067548773,0,0,1
214,Positive Regulation Of Behavior (GO:0048520),0.15148478834593684,8.98235294117647,16.952125828410935,['NR4A3'],0.30364888067548773,0,0,1
215,Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),0.15148478834593684,8.98235294117647,16.952125828410935,['RAET1E'],0.30364888067548773,0,0,1
216,Cytosolic Transport (GO:0016482),0.15148478834593684,8.98235294117647,16.952125828410935,['TBC1D10C'],0.30364888067548773,0,0,1
217,Positive Regulation Of Cell Communication (GO:0010647),0.15148478834593684,8.98235294117647,16.952125828410935,['HOMER1'],0.30364888067548773,0,0,1
218,Positive Regulation Of Cell Cycle G1/S Phase Transition (GO:1902808),0.15148478834593684,8.98235294117647,16.952125828410935,['ADAMTS1'],0.30364888067548773,0,0,1
219,Regulation Of Acute Inflammatory Response (GO:0002673),0.15148478834593684,8.98235294117647,16.952125828410935,['PTGES'],0.30364888067548773,0,0,1
220,Regulation Of Angiotensin Levels In Blood (GO:0002002),0.15148478834593684,8.98235294117647,16.952125828410935,['ENPEP'],0.30364888067548773,0,0,1
221,Development Of Primary Male Sexual Characteristics (GO:0046546),0.15148478834593684,8.98235294117647,16.952125828410935,['BIK'],0.30364888067548773,0,0,1
222,Sensory Perception Of Pain (GO:0019233),0.15148478834593684,8.98235294117647,16.952125828410935,['PTGES'],0.30364888067548773,0,0,1
223,Negative Regulation Of Cell Cycle Process (GO:0010948),0.15148478834593684,8.98235294117647,16.952125828410935,['FOXO4'],0.30364888067548773,0,0,1
224,Regulation Of Signal Transduction (GO:0009966),0.1686669305503417,3.009920634920635,5.357145038550889,"['HOMER1', 'UBASH3B']",0.3365808837321551,0,0,2
225,Negative Regulation Of Protein Kinase Activity (GO:0006469),0.18820399638080115,2.7765567765567765,4.637485141079694,"['SPRED1', 'UBASH3B']",0.3503926303426705,0,0,2
226,Regulation Of Protein Kinase Activity (GO:0045859),0.18820399638080115,2.7765567765567765,4.637485141079694,"['SPRED1', 'UBASH3B']",0.3503926303426705,0,0,2
227,DNA-templated DNA Replication (GO:0006261),0.19675290876064944,5.984313725490196,9.729336797750657,['CDK2AP1'],0.3503926303426705,0,0,1
228,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:1902230),0.19675290876064944,5.984313725490196,9.729336797750657,['SFRP2'],0.3503926303426705,0,0,1
229,"G Protein-Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger (GO:0007187)",0.19675290876064944,5.984313725490196,9.729336797750657,['CHRM5'],0.3503926303426705,0,0,1
230,Regulation Of Feeding Behavior (GO:0060259),0.19675290876064944,5.984313725490196,9.729336797750657,['NR4A3'],0.3503926303426705,0,0,1
231,Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),0.19675290876064944,5.984313725490196,9.729336797750657,['SFRP2'],0.3503926303426705,0,0,1
232,Negative Regulation Of Response To Stimulus (GO:0048585),0.19675290876064944,5.984313725490196,9.729336797750657,['UBASH3B'],0.3503926303426705,0,0,1
233,Homotypic Cell-Cell Adhesion (GO:0034109),0.19675290876064944,5.984313725490196,9.729336797750657,['UBASH3B'],0.3503926303426705,0,0,1
234,Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031110),0.19675290876064944,5.984313725490196,9.729336797750657,['STMND1'],0.3503926303426705,0,0,1
235,Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0042269),0.19675290876064944,5.984313725490196,9.729336797750657,['RAET1E'],0.3503926303426705,0,0,1
236,Regulation Of Postsynapse Organization (GO:0099175),0.19675290876064944,5.984313725490196,9.729336797750657,['HOMER1'],0.3503926303426705,0,0,1
237,Organic Hydroxy Compound Transport (GO:0015850),0.19675290876064944,5.984313725490196,9.729336797750657,['SLC5A3'],0.3503926303426705,0,0,1
238,Organonitrogen Compound Catabolic Process (GO:1901565),0.19675290876064944,5.984313725490196,9.729336797750657,['ENPEP'],0.3503926303426705,0,0,1
239,Protein Depolymerization (GO:0051261),0.19675290876064944,5.984313725490196,9.729336797750657,['STMND1'],0.3503926303426705,0,0,1
240,Cardiac Ventricle Morphogenesis (GO:0003208),0.19675290876064944,5.984313725490196,9.729336797750657,['SFRP2'],0.3503926303426705,0,0,1
241,Peptidyl-Tyrosine Dephosphorylation (GO:0035335),0.19675290876064944,5.984313725490196,9.729336797750657,['UBASH3B'],0.3503926303426705,0,0,1
242,Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),0.19675290876064944,5.984313725490196,9.729336797750657,['MRAP'],0.3503926303426705,0,0,1
243,Protein Tetramerization (GO:0051262),0.19675290876064944,5.984313725490196,9.729336797750657,['HOMER1'],0.3503926303426705,0,0,1
244,Platelet Aggregation (GO:0070527),0.19675290876064944,5.984313725490196,9.729336797750657,['UBASH3B'],0.3503926303426705,0,0,1
245,Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),0.19675290876064944,5.984313725490196,9.729336797750657,['PSG4'],0.3503926303426705,0,0,1
246,Natural Killer Cell Mediated Cytotoxicity (GO:0042267),0.19675290876064944,5.984313725490196,9.729336797750657,['RAET1E'],0.3503926303426705,0,0,1
247,Positive Regulation Of Biosynthetic Process (GO:0009891),0.19675290876064944,5.984313725490196,9.729336797750657,['SLC5A3'],0.3503926303426705,0,0,1
248,Regulation Of Bone Resorption (GO:0045124),0.19675290876064944,5.984313725490196,9.729336797750657,['UBASH3B'],0.3503926303426705,0,0,1
249,Sensory Perception (GO:0007600),0.19675290876064944,5.984313725490196,9.729336797750657,['PTGES'],0.3503926303426705,0,0,1
250,Endocytic Recycling (GO:0032456),0.19675290876064944,5.984313725490196,9.729336797750657,['TRARG1'],0.3503926303426705,0,0,1
251,Endosome To Lysosome Transport (GO:0008333),0.19675290876064944,5.984313725490196,9.729336797750657,['PLEKHF1'],0.3503926303426705,0,0,1
252,Regulation Of Epithelial Cell Proliferation (GO:0050678),0.2080376083502539,2.576530612244898,4.045246863038597,"['SFRP2', 'NR4A3']",0.36901909100223607,0,0,2
253,Regulation Of Cell Population Proliferation (GO:0042127),0.22134715382873663,1.6236772486772486,2.4485426000655792,"['FGF17', 'SFRP2', 'NR4A3', 'ADAMTS1', 'FOXO4']",0.37716818713021955,0,0,5
254,Positive Regulation Of DNA-templated Transcription (GO:0045893),0.22284533301110876,1.5401408450704226,2.312178523539399,"['EHF', 'SFRP2', 'NR4A3', 'NFATC2', 'FOXO4', 'ETV5']",0.37716818713021955,0,0,6
255,Positive Regulation Of Protein Phosphorylation (GO:0001934),0.2261761523791263,1.9376075731497417,2.8801396254176903,"['FGF17', 'SFRP2', 'CDK2AP1']",0.37716818713021955,0,0,3
256,Positive Regulation Of Phosphorylation (GO:0042327),0.22808208535743282,2.403174603174603,3.5520114804177174,"['FGF17', 'CDK2AP1']",0.37716818713021955,0,0,2
257,Anterograde Trans-Synaptic Signaling (GO:0098916),0.22808208535743282,2.403174603174603,3.5520114804177174,"['HOMER1', 'CHRM5']",0.37716818713021955,0,0,2
258,Organelle Organization (GO:0006996),0.22808208535743282,2.403174603174603,3.5520114804177174,"['MRAP', 'PLEKHF1']",0.37716818713021955,0,0,2
259,Positive Regulation Of Growth (GO:0045927),0.23963258421696274,4.485294117647059,6.407908389215383,['SFRP2'],0.37716818713021955,0,0,1
260,Positive Regulation Of Immune Effector Process (GO:0002699),0.23963258421696274,4.485294117647059,6.407908389215383,['COLEC11'],0.37716818713021955,0,0,1
261,DNA Replication (GO:0006260),0.23963258421696274,4.485294117647059,6.407908389215383,['CDK2AP1'],0.37716818713021955,0,0,1
262,Fibroblast Growth Factor Receptor Signaling Pathway (GO:0008543),0.23963258421696274,4.485294117647059,6.407908389215383,['FGF17'],0.37716818713021955,0,0,1
263,Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),0.23963258421696274,4.485294117647059,6.407908389215383,['PSG4'],0.37716818713021955,0,0,1
264,Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),0.23963258421696274,4.485294117647059,6.407908389215383,['ADAMTS1'],0.37716818713021955,0,0,1
265,Transport Across Blood-Brain Barrier (GO:0150104),0.23963258421696274,4.485294117647059,6.407908389215383,['SLC5A3'],0.37716818713021955,0,0,1
266,Vascular Transport (GO:0010232),0.23963258421696274,4.485294117647059,6.407908389215383,['SLC5A3'],0.37716818713021955,0,0,1
267,Wnt Signaling Pathway (GO:0016055),0.23963258421696274,4.485294117647059,6.407908389215383,['SFRP2'],0.37716818713021955,0,0,1
268,Positive Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090200),0.23963258421696274,4.485294117647059,6.407908389215383,['BIK'],0.37716818713021955,0,0,1
269,Regulation Of Microtubule Cytoskeleton Organization (GO:0070507),0.23963258421696274,4.485294117647059,6.407908389215383,['STMND1'],0.37716818713021955,0,0,1
270,Positive Regulation Of Response To Stimulus (GO:0048584),0.23963258421696274,4.485294117647059,6.407908389215383,['HOMER1'],0.37716818713021955,0,0,1
271,Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),0.23963258421696274,4.485294117647059,6.407908389215383,['NR4A3'],0.37716818713021955,0,0,1
272,Apoptotic Mitochondrial Changes (GO:0008637),0.23963258421696274,4.485294117647059,6.407908389215383,['BIK'],0.37716818713021955,0,0,1
273,Regulation Of Osteoclast Differentiation (GO:0045670),0.23963258421696274,4.485294117647059,6.407908389215383,['UBASH3B'],0.37716818713021955,0,0,1
274,Protein Complex Oligomerization (GO:0051259),0.23963258421696274,4.485294117647059,6.407908389215383,['HOMER1'],0.37716818713021955,0,0,1
275,Peptide Metabolic Process (GO:0006518),0.23963258421696274,4.485294117647059,6.407908389215383,['ENPEP'],0.37716818713021955,0,0,1
276,Cell Junction Organization (GO:0034330),0.23963258421696274,4.485294117647059,6.407908389215383,['ELFN1'],0.37716818713021955,0,0,1
277,Modulation Of Chemical Synaptic Transmission (GO:0050804),0.23963258421696274,4.485294117647059,6.407908389215383,['HOMER1'],0.37716818713021955,0,0,1
278,Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),0.23963258421696274,4.485294117647059,6.407908389215383,['NR4A3'],0.37716818713021955,0,0,1
279,Natural Killer Cell Mediated Immunity (GO:0002228),0.23963258421696274,4.485294117647059,6.407908389215383,['RAET1E'],0.37716818713021955,0,0,1
280,Response To Insulin (GO:0032868),0.23963258421696274,4.485294117647059,6.407908389215383,['TRARG1'],0.37716818713021955,0,0,1
281,Positive Regulation Of Cell Adhesion (GO:0045785),0.23963258421696274,4.485294117647059,6.407908389215383,['SFRP2'],0.37716818713021955,0,0,1
282,Regulation Of Cation Channel Activity (GO:2001257),0.23963258421696274,4.485294117647059,6.407908389215383,['HOMER1'],0.37716818713021955,0,0,1
283,Endomembrane System Organization (GO:0010256),0.23963258421696274,4.485294117647059,6.407908389215383,['PLEKHF1'],0.37716818713021955,0,0,1
284,Positive Regulation Of Fat Cell Differentiation (GO:0045600),0.23963258421696274,4.485294117647059,6.407908389215383,['SFRP2'],0.37716818713021955,0,0,1
285,Central Nervous System Development (GO:0007417),0.24825983772367113,2.2514880952380953,3.136951866599841,"['NMUR2', 'PCDH18']",0.3893759560087052,0,0,2
286,Regulation Of Gene Expression (GO:0010468),0.2516811048405626,1.5379786566227245,2.1217837426601394,"['FGF17', 'SFRP2', 'PSG4', 'NFATC2', 'FOXO4']",0.3933617267962639,0,0,5
287,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),0.2620299569271674,1.5113168724279835,2.0241013104921564,"['EHF', 'SFRP2', 'NR4A3', 'FOXO4', 'ETV5']",0.3976858634161926,0,0,5
288,Regulation Of Intracellular Signal Transduction (GO:1902531),0.26850076472840095,2.1176470588235294,2.784497329877939,"['MRAP', 'SPRED1']",0.3976858634161926,0,0,2
289,Vesicle-Mediated Transport (GO:0016192),0.26850076472840095,2.1176470588235294,2.784497329877939,"['MYO1E', 'PLEKHF1']",0.3976858634161926,0,0,2
290,Positive Regulation Of Protein Modification Process (GO:0031401),0.26850076472840095,2.1176470588235294,2.784497329877939,"['FGF17', 'CDK2AP1']",0.3976858634161926,0,0,2
291,Regulation Of DNA-templated Transcription (GO:0006355),0.2800236974281131,1.3681774874098271,1.7415271909079053,"['EHF', 'SFRP2', 'NR4A3', 'CDK2AP1', 'NFATC2', 'FOXO4', 'ETV5']",0.3976858634161926,0,0,7
292,Regulation Of Cytosolic Calcium Ion Concentration (GO:0051480),0.2802484272395988,3.5858823529411765,4.561525024591494,['SCGN'],0.3976858634161926,0,0,1
293,Regulation Of Defense Response (GO:0031347),0.2802484272395988,3.5858823529411765,4.561525024591494,['PTGES'],0.3976858634161926,0,0,1
294,Fat Cell Differentiation (GO:0045444),0.2802484272395988,3.5858823529411765,4.561525024591494,['NR4A3'],0.3976858634161926,0,0,1
295,Regulation Of Fat Cell Differentiation (GO:0045598),0.2802484272395988,3.5858823529411765,4.561525024591494,['SFRP2'],0.3976858634161926,0,0,1
296,Hemopoiesis (GO:0030097),0.2802484272395988,3.5858823529411765,4.561525024591494,['SFRP2'],0.3976858634161926,0,0,1
297,Positive Regulation Of Peptide Hormone Secretion (GO:0090277),0.2802484272395988,3.5858823529411765,4.561525024591494,['RASL10B'],0.3976858634161926,0,0,1
298,Positive Regulation Of Phagocytosis (GO:0050766),0.2802484272395988,3.5858823529411765,4.561525024591494,['COLEC11'],0.3976858634161926,0,0,1
299,Adenylate Cyclase-Inhibiting G Protein-Coupled Receptor Signaling Pathway (GO:0007193),0.2802484272395988,3.5858823529411765,4.561525024591494,['CHRM5'],0.3976858634161926,0,0,1
300,Positive Regulation Of Protein Localization To Membrane (GO:1905477),0.2802484272395988,3.5858823529411765,4.561525024591494,['SLC5A3'],0.3976858634161926,0,0,1
301,Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),0.2802484272395988,3.5858823529411765,4.561525024591494,['SLC5A3'],0.3976858634161926,0,0,1
302,Branching Morphogenesis Of An Epithelial Tube (GO:0048754),0.2802484272395988,3.5858823529411765,4.561525024591494,['SFRP2'],0.3976858634161926,0,0,1
303,Canonical Wnt Signaling Pathway (GO:0060070),0.2802484272395988,3.5858823529411765,4.561525024591494,['SFRP2'],0.3976858634161926,0,0,1
304,Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),0.2802484272395988,3.5858823529411765,4.561525024591494,['NEFH'],0.3976858634161926,0,0,1
305,Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),0.2802484272395988,3.5858823529411765,4.561525024591494,['NR4A3'],0.3976858634161926,0,0,1
306,"Regulation Of Synaptic Transmission, Glutamatergic (GO:0051966)",0.2802484272395988,3.5858823529411765,4.561525024591494,['HOMER1'],0.3976858634161926,0,0,1
307,Positive Regulation Of B Cell Proliferation (GO:0030890),0.2802484272395988,3.5858823529411765,4.561525024591494,['NFATC2'],0.3976858634161926,0,0,1
308,Regulation Of B Cell Proliferation (GO:0030888),0.2802484272395988,3.5858823529411765,4.561525024591494,['NFATC2'],0.3976858634161926,0,0,1
309,Positive Regulation Of Canonical Wnt Signaling Pathway (GO:0090263),0.2802484272395988,3.5858823529411765,4.561525024591494,['SFRP2'],0.3976858634161926,0,0,1
310,Positive Regulation Of Catalytic Activity (GO:0043085),0.2802484272395988,3.5858823529411765,4.561525024591494,['SLC5A3'],0.3976858634161926,0,0,1
311,Positive Regulation Of Cell Growth (GO:0030307),0.2802484272395988,3.5858823529411765,4.561525024591494,['SFRP2'],0.3976858634161926,0,0,1
312,Positive Regulation Of Cellular Catabolic Process (GO:0031331),0.2802484272395988,3.5858823529411765,4.561525024591494,['PLEKHF1'],0.3976858634161926,0,0,1
313,Positive Regulation Of Cellular Component Organization (GO:0051130),0.2802484272395988,3.5858823529411765,4.561525024591494,['BIK'],0.3976858634161926,0,0,1
314,Second-Messenger-Mediated Signaling (GO:0019932),0.2802484272395988,3.5858823529411765,4.561525024591494,['NMUR2'],0.3976858634161926,0,0,1
315,Regulation Of Calcium Ion Transport (GO:0051924),0.2802484272395988,3.5858823529411765,4.561525024591494,['HOMER1'],0.3976858634161926,0,0,1
316,Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),0.2887416922862093,1.9986772486772486,2.482802425889293,"['NFATC2', 'FOXO4']",0.4058727561381621,0,0,2
317,Regulation Of Protein Phosphorylation (GO:0001932),0.2887416922862093,1.9986772486772486,2.482802425889293,"['FGF17', 'CDK2AP1']",0.4058727561381621,0,0,2
318,Chemical Synaptic Transmission (GO:0007268),0.2887416922862093,1.9986772486772486,2.482802425889293,"['HOMER1', 'CHRM5']",0.4058727561381621,0,0,2
319,Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),0.31871862322286704,2.9862745098039216,3.4146455074762065,['SFRP2'],0.4240095969661356,0,0,1
320,Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),0.31871862322286704,2.9862745098039216,3.4146455074762065,['SFRP2'],0.4240095969661356,0,0,1
321,Vesicle Organization (GO:0016050),0.31871862322286704,2.9862745098039216,3.4146455074762065,['PLEKHF1'],0.4240095969661356,0,0,1
322,Positive Regulation Of Protein Localization (GO:1903829),0.31871862322286704,2.9862745098039216,3.4146455074762065,['SLC5A3'],0.4240095969661356,0,0,1
323,Integrin-Mediated Signaling Pathway (GO:0007229),0.31871862322286704,2.9862745098039216,3.4146455074762065,['ADAMTS1'],0.4240095969661356,0,0,1
324,Antigen Receptor-Mediated Signaling Pathway (GO:0050851),0.31871862322286704,2.9862745098039216,3.4146455074762065,['NFATC2'],0.4240095969661356,0,0,1
325,Regulation Of Peptide Hormone Secretion (GO:0090276),0.31871862322286704,2.9862745098039216,3.4146455074762065,['RASL10B'],0.4240095969661356,0,0,1
326,Lysosomal Transport (GO:0007041),0.31871862322286704,2.9862745098039216,3.4146455074762065,['PLEKHF1'],0.4240095969661356,0,0,1
327,Lysosome Localization (GO:0032418),0.31871862322286704,2.9862745098039216,3.4146455074762065,['NR4A3'],0.4240095969661356,0,0,1
328,Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),0.31871862322286704,2.9862745098039216,3.4146455074762065,['UBASH3B'],0.4240095969661356,0,0,1
329,Cellular Response To Fibroblast Growth Factor Stimulus (GO:0044344),0.31871862322286704,2.9862745098039216,3.4146455074762065,['FGF17'],0.4240095969661356,0,0,1
330,Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),0.31871862322286704,2.9862745098039216,3.4146455074762065,['MRAP'],0.4240095969661356,0,0,1
331,Positive Regulation Of B Cell Activation (GO:0050871),0.31871862322286704,2.9862745098039216,3.4146455074762065,['NFATC2'],0.4240095969661356,0,0,1
332,Positive Regulation Of Wnt Signaling Pathway (GO:0030177),0.31871862322286704,2.9862745098039216,3.4146455074762065,['SFRP2'],0.4240095969661356,0,0,1
333,Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),0.31871862322286704,2.9862745098039216,3.4146455074762065,['PLEKHF1'],0.4240095969661356,0,0,1
334,Cytoskeleton Organization (GO:0007010),0.31871862322286704,2.9862745098039216,3.4146455074762065,['MRAP'],0.4240095969661356,0,0,1
335,Negative Regulation Of Cell Motility (GO:2000146),0.31871862322286704,2.9862745098039216,3.4146455074762065,['SFRP2'],0.4240095969661356,0,0,1
336,Endosomal Transport (GO:0016197),0.31871862322286704,2.9862745098039216,3.4146455074762065,['TBC1D10C'],0.4240095969661356,0,0,1
337,Negative Regulation Of Cell Population Proliferation (GO:0008285),0.344673983721685,1.498995983935743,1.596664991141413,"['SFRP2', 'ADAMTS1', 'FOXO4']",0.4484587576482133,0,0,3
338,Regulation Of Transcription By RNA Polymerase II (GO:0006357),0.35083459066695066,1.2527885699962402,1.3122213837373622,"['EHF', 'SFRP2', 'NR4A3', 'CDK2AP1', 'NFATC2', 'FOXO4', 'ETV5']",0.4484587576482133,0,0,7
339,'De Novo' Post-Translational Protein Folding (GO:0051084),0.35515525773482665,2.5579831932773107,2.648024814017301,['DNAJB5'],0.4484587576482133,0,0,1
340,Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001242),0.35515525773482665,2.5579831932773107,2.648024814017301,['PLEKHF1'],0.4484587576482133,0,0,1
341,Regulation Of Monoatomic Ion Transmembrane Transporter Activity (GO:0032412),0.35515525773482665,2.5579831932773107,2.648024814017301,['HOMER1'],0.4484587576482133,0,0,1
342,Antimicrobial Humoral Response (GO:0019730),0.35515525773482665,2.5579831932773107,2.648024814017301,['COLEC11'],0.4484587576482133,0,0,1
343,Apical Junction Assembly (GO:0043297),0.35515525773482665,2.5579831932773107,2.648024814017301,['CLDN9'],0.4484587576482133,0,0,1
344,Bicellular Tight Junction Assembly (GO:0070830),0.35515525773482665,2.5579831932773107,2.648024814017301,['CLDN9'],0.4484587576482133,0,0,1
345,Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),0.35515525773482665,2.5579831932773107,2.648024814017301,['SFRP2'],0.4484587576482133,0,0,1
346,Calcium Ion Transport (GO:0006816),0.35515525773482665,2.5579831932773107,2.648024814017301,['NMUR2'],0.4484587576482133,0,0,1
347,Regulation Of Response To External Stimulus (GO:0032101),0.35515525773482665,2.5579831932773107,2.648024814017301,['PTGES'],0.4484587576482133,0,0,1
348,Cellular Response To Chemical Stress (GO:0062197),0.35515525773482665,2.5579831932773107,2.648024814017301,['ETV5'],0.4484587576482133,0,0,1
349,Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),0.35515525773482665,2.5579831932773107,2.648024814017301,['DNAJB5'],0.4484587576482133,0,0,1
350,Positive Regulation Of Autophagy (GO:0010508),0.35515525773482665,2.5579831932773107,2.648024814017301,['PLEKHF1'],0.4484587576482133,0,0,1
351,Regulation Of Wnt Signaling Pathway (GO:0030111),0.35515525773482665,2.5579831932773107,2.648024814017301,['SFRP2'],0.4484587576482133,0,0,1
352,Positive Regulation Of Cellular Metabolic Process (GO:0031325),0.35515525773482665,2.5579831932773107,2.648024814017301,['YPEL3'],0.4484587576482133,0,0,1
353,Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),0.35515525773482665,2.5579831932773107,2.648024814017301,['SFRP2'],0.4484587576482133,0,0,1
354,Endocytosis (GO:0006897),0.35515525773482665,2.5579831932773107,2.648024814017301,['MYO1E'],0.4484587576482133,0,0,1
355,Negative Regulation Of Signal Transduction (GO:0009968),0.36865593948730996,1.630952380952381,1.6275134904943733,"['SFRP2', 'UBASH3B']",0.46289102514277397,0,0,2
356,Regulation Of ERK1 And ERK2 Cascade (GO:0070372),0.36865593948730996,1.630952380952381,1.6275134904943733,"['SPRED2', 'SPRED1']",0.46289102514277397,0,0,2
357,Positive Regulation Of Cell Population Proliferation (GO:0008284),0.3894120777317465,1.3809082483781279,1.3023582796056583,"['FGF17', 'SFRP2', 'NR4A3']",0.46448023582360504,0,0,3
358,Negative Regulation Of Cellular Process (GO:0048523),0.3894120777317465,1.3809082483781279,1.3023582796056583,"['SFRP2', 'ADAMTS1', 'FOXO4']",0.46448023582360504,0,0,3
359,Sterol Homeostasis (GO:0055092),0.3896646273687962,2.236764705882353,2.1080810368867766,['MALL'],0.46448023582360504,0,0,1
360,Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),0.3896646273687962,2.236764705882353,2.1080810368867766,['PLEKHF1'],0.46448023582360504,0,0,1
361,Positive Regulation Of Lymphocyte Proliferation (GO:0050671),0.3896646273687962,2.236764705882353,2.1080810368867766,['NFATC2'],0.46448023582360504,0,0,1
362,Tight Junction Assembly (GO:0120192),0.3896646273687962,2.236764705882353,2.1080810368867766,['CLDN9'],0.46448023582360504,0,0,1
363,Positive Regulation Of Mitochondrion Organization (GO:0010822),0.3896646273687962,2.236764705882353,2.1080810368867766,['BIK'],0.46448023582360504,0,0,1
364,Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),0.3896646273687962,2.236764705882353,2.1080810368867766,['PSG4'],0.46448023582360504,0,0,1
365,Actin Filament Organization (GO:0007015),0.3896646273687962,2.236764705882353,2.1080810368867766,['MYO1E'],0.46448023582360504,0,0,1
366,Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),0.3896646273687962,2.236764705882353,2.1080810368867766,['BIK'],0.46448023582360504,0,0,1
367,Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730),0.3896646273687962,2.236764705882353,2.1080810368867766,['SFRP2'],0.46448023582360504,0,0,1
368,Protein Dephosphorylation (GO:0006470),0.3896646273687962,2.236764705882353,2.1080810368867766,['UBASH3B'],0.46448023582360504,0,0,1
369,Plasma Membrane Bounded Cell Projection Organization (GO:0120036),0.3896646273687962,2.236764705882353,2.1080810368867766,['STMND1'],0.46448023582360504,0,0,1
370,Positive Regulation Of GTPase Activity (GO:0043547),0.3896646273687962,2.236764705882353,2.1080810368867766,['TBC1D10C'],0.46448023582360504,0,0,1
371,Cholesterol Homeostasis (GO:0042632),0.3896646273687962,2.236764705882353,2.1080810368867766,['MALL'],0.46448023582360504,0,0,1
372,Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),0.3896646273687962,2.236764705882353,2.1080810368867766,['ADAMTS1'],0.46448023582360504,0,0,1
373,Response To Calcium Ion (GO:0051592),0.3896646273687962,2.236764705882353,2.1080810368867766,['HOMER1'],0.46448023582360504,0,0,1
374,Regulation Of T Cell Differentiation (GO:0045580),0.3896646273687962,2.236764705882353,2.1080810368867766,['PSG4'],0.46448023582360504,0,0,1
375,Positive Regulation Of Cellular Component Biogenesis (GO:0044089),0.3896646273687962,2.236764705882353,2.1080810368867766,['BIK'],0.46448023582360504,0,0,1
376,Negative Regulation Of Intracellular Signal Transduction (GO:1902532),0.40739717124959124,1.4930555555555556,1.3407141979638295,"['SPRED2', 'SPRED1']",0.4830412083516374,0,0,2
377,Nervous System Development (GO:0007399),0.40739717124959124,1.4930555555555556,1.3407141979638295,"['FGF17', 'NMUR2']",0.4830412083516374,0,0,2
378,Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),0.42234753521252555,1.9869281045751634,1.7125865049482392,['SFRP2'],0.4890915757512925,0,0,1
379,Neuron Development (GO:0048666),0.42234753521252555,1.9869281045751634,1.7125865049482392,['STMND1'],0.4890915757512925,0,0,1
380,Neuron Projection Morphogenesis (GO:0048812),0.42234753521252555,1.9869281045751634,1.7125865049482392,['NEFH'],0.4890915757512925,0,0,1
381,Neuropeptide Signaling Pathway (GO:0007218),0.42234753521252555,1.9869281045751634,1.7125865049482392,['NMUR2'],0.4890915757512925,0,0,1
382,Axon Development (GO:0061564),0.42234753521252555,1.9869281045751634,1.7125865049482392,['NEFH'],0.4890915757512925,0,0,1
383,Brain Development (GO:0007420),0.42234753521252555,1.9869281045751634,1.7125865049482392,['PCDH18'],0.4890915757512925,0,0,1
384,Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),0.42234753521252555,1.9869281045751634,1.7125865049482392,['BIK'],0.4890915757512925,0,0,1
385,Negative Regulation Of Wnt Signaling Pathway (GO:0030178),0.42234753521252555,1.9869281045751634,1.7125865049482392,['SFRP2'],0.4890915757512925,0,0,1
386,Endosome Organization (GO:0007032),0.42234753521252555,1.9869281045751634,1.7125865049482392,['PLEKHF1'],0.4890915757512925,0,0,1
387,Regulation Of MAPK Cascade (GO:0043408),0.44498928007230165,1.3763736263736264,1.1144567266550636,"['SPRED2', 'SPRED1']",0.512655175753399,0,0,2
388,Regulation Of Cell Migration (GO:0030334),0.44498928007230165,1.3763736263736264,1.1144567266550636,"['FGF17', 'SFRP2']",0.512655175753399,0,0,2
389,Synapse Organization (GO:0050808),0.4532995717623781,1.7870588235294118,1.4139246327879755,['ELFN1'],0.5129744520956532,0,0,1
390,Extracellular Structure Organization (GO:0043062),0.4532995717623781,1.7870588235294118,1.4139246327879755,['ADAMTS1'],0.5129744520956532,0,0,1
391,Regulation Of Protein-Containing Complex Assembly (GO:0043254),0.4532995717623781,1.7870588235294118,1.4139246327879755,['BIK'],0.5129744520956532,0,0,1
392,Metal Ion Transport (GO:0030001),0.4532995717623781,1.7870588235294118,1.4139246327879755,['NMUR2'],0.5129744520956532,0,0,1
393,Regulation Of GTPase Activity (GO:0043087),0.4532995717623781,1.7870588235294118,1.4139246327879755,['MRAP'],0.5129744520956532,0,0,1
394,Response To Metal Ion (GO:0010038),0.4532995717623781,1.7870588235294118,1.4139246327879755,['HOMER1'],0.5129744520956532,0,0,1
395,Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),0.4532995717623781,1.7870588235294118,1.4139246327879755,['SFRP2'],0.5129744520956532,0,0,1
396,Negative Regulation Of Growth (GO:0045926),0.48261138094610206,1.6235294117647059,1.182811870629678,['SFRP2'],0.5326599685997718,0,0,1
397,External Encapsulating Structure Organization (GO:0045229),0.48261138094610206,1.6235294117647059,1.182811870629678,['ADAMTS1'],0.5326599685997718,0,0,1
398,Fatty Acid Metabolic Process (GO:0006631),0.48261138094610206,1.6235294117647059,1.182811870629678,['HAO2'],0.5326599685997718,0,0,1
399,Axonogenesis (GO:0007409),0.48261138094610206,1.6235294117647059,1.182811870629678,['NEFH'],0.5326599685997718,0,0,1
400,Calcium-Mediated Signaling (GO:0019722),0.48261138094610206,1.6235294117647059,1.182811870629678,['NMUR2'],0.5326599685997718,0,0,1
401,Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),0.48261138094610206,1.6235294117647059,1.182811870629678,['CLDN9'],0.5326599685997718,0,0,1
402,Response To Unfolded Protein (GO:0006986),0.48261138094610206,1.6235294117647059,1.182811870629678,['DNAJB5'],0.5326599685997718,0,0,1
403,Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),0.48261138094610206,1.6235294117647059,1.182811870629678,['NR4A3'],0.5326599685997718,0,0,1
404,Regulation Of Cell Division (GO:0051302),0.48261138094610206,1.6235294117647059,1.182811870629678,['SFRP2'],0.5326599685997718,0,0,1
405,Regulation Of Cell Motility (GO:2000145),0.48261138094610206,1.6235294117647059,1.182811870629678,['FGF17'],0.5326599685997718,0,0,1
406,Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),0.49884478321843134,1.2315270935960592,0.8564781863213738,"['FGF17', 'PSG4']",0.5492207342331005,0,0,2
407,Epithelium Development (GO:0060429),0.5103689135339674,1.4872549019607844,1.0003595559519654,['EHF'],0.5497226610835745,0,0,1
408,Extracellular Matrix Organization (GO:0030198),0.5103689135339674,1.4872549019607844,1.0003595559519654,['ADAMTS1'],0.5497226610835745,0,0,1
409,Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),0.5103689135339674,1.4872549019607844,1.0003595559519654,['SFRP2'],0.5497226610835745,0,0,1
410,Positive Regulation Of Vasculature Development (GO:1904018),0.5103689135339674,1.4872549019607844,1.0003595559519654,['SFRP2'],0.5497226610835745,0,0,1
411,Organic Substance Transport (GO:0071702),0.5103689135339674,1.4872549019607844,1.0003595559519654,['NMUR2'],0.5497226610835745,0,0,1
412,Cellular Response To Hormone Stimulus (GO:0032870),0.5103689135339674,1.4872549019607844,1.0003595559519654,['NR4A3'],0.5497226610835745,0,0,1
413,Cellular Response To Oxidative Stress (GO:0034599),0.5103689135339674,1.4872549019607844,1.0003595559519654,['ETV5'],0.5497226610835745,0,0,1
414,Negative Regulation Of Cell Growth (GO:0030308),0.5103689135339674,1.4872549019607844,1.0003595559519654,['SFRP2'],0.5497226610835745,0,0,1
415,Negative Regulation Of Cytokine Production (GO:0001818),0.5103689135339674,1.4872549019607844,1.0003595559519654,['PSG4'],0.5497226610835745,0,0,1
416,Skeletal System Development (GO:0001501),0.5366536671077823,1.371945701357466,0.8539022049252459,['PRELP'],0.5766446855701411,0,0,1
417,Epithelial Cell Differentiation (GO:0030855),0.5615429141998605,1.273109243697479,0.7346694337071846,['EHF'],0.5948096745197574,0,0,1
418,Regulation Of Inflammatory Response (GO:0050727),0.5615429141998605,1.273109243697479,0.7346694337071846,['PTGES'],0.5948096745197574,0,0,1
419,Intracellular Protein Transport (GO:0006886),0.5615429141998605,1.273109243697479,0.7346694337071846,['TRARG1'],0.5948096745197574,0,0,1
420,Pyruvate Metabolic Process (GO:0006090),0.5615429141998605,1.273109243697479,0.7346694337071846,['NR4A3'],0.5948096745197574,0,0,1
421,Positive Regulation Of Angiogenesis (GO:0045766),0.5615429141998605,1.273109243697479,0.7346694337071846,['SFRP2'],0.5948096745197574,0,0,1
422,Negative Regulation Of Cell Migration (GO:0030336),0.5615429141998605,1.273109243697479,0.7346694337071846,['SFRP2'],0.5948096745197574,0,0,1
423,Positive Regulation Of Cell Differentiation (GO:0045597),0.5851099188557459,1.187450980392157,0.6364209479495403,['SFRP2'],0.6183076447482706,0,0,1
424,Positive Regulation Of Gene Expression (GO:0010628),0.5961834012351581,1.0163265306122449,0.525651133983141,"['FGF17', 'PSG4']",0.6285235385663106,0,0,2
425,DNA Damage Response (GO:0006974),0.6074241421950374,1.1125,0.5546123781715778,['NFATC2'],0.6358749216889502,0,0,1
426,Positive Regulation Of Signal Transduction (GO:0009967),0.6074241421950374,1.1125,0.5546123781715778,['HOMER1'],0.6358749216889502,0,0,1
427,Cellular Component Assembly (GO:0022607),0.6074241421950374,1.1125,0.5546123781715778,['NEFH'],0.6358749216889502,0,0,1
428,Negative Regulation Of Gene Expression (GO:0010629),0.6285514374656743,1.0463667820069205,0.48586724425960737,['SFRP2'],0.6564544218391505,0,0,1
429,Negative Regulation Of DNA-templated Transcription (GO:0045892),0.6419233795087957,0.9167012879102617,0.4063611486835249,"['SFRP2', 'NR4A3', 'ETV5']",0.6688572276000738,0,0,3
430,Energy Derivation By Oxidation Of Organic Compounds (GO:0015980),0.6485542355198098,0.9875816993464053,0.4276324024881598,['NR4A3'],0.6741947518078023,0,0,1
431,Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),0.6529509512222373,0.9096459096459096,0.38773953944403644,"['NR4A3', 'ETV5']",0.6771904296898842,0,0,2
432,Regulation Of Programmed Cell Death (GO:0043067),0.6674917203829073,0.934984520123839,0.37794719627563705,['BIK'],0.6890734388248488,0,0,1
433,Regulation Of Cell Growth (GO:0001558),0.6674917203829073,0.934984520123839,0.37794719627563705,['SFRP2'],0.6890734388248488,0,0,1
434,Positive Regulation Of Cellular Process (GO:0048522),0.6789053776712612,0.8641114982578397,0.3346474986234924,"['FGF17', 'SFRP2']",0.6992412530392944,0,0,2
435,Apoptotic Process (GO:0006915),0.6854199962654735,0.8876470588235295,0.3352851497181871,['BIK'],0.702712702593272,0,0,1
436,Cellular Response To Organic Cyclic Compound (GO:0071407),0.6854199962654735,0.8876470588235295,0.3352851497181871,['NR4A3'],0.702712702593272,0,0,1
437,Positive Regulation Of Intracellular Signal Transduction (GO:1902533),0.7032812501092528,0.82281284606866,0.2896288019416568,"['FRMD6', 'PLEKHF1']",0.7193746425602654,0,0,2
438,Positive Regulation Of Programmed Cell Death (GO:0043068),0.7336676869041523,0.7703324808184143,0.23857127256215135,['SFRP2'],0.7487430503336897,0,0,1
439,Mitochondrion Organization (GO:0007005),0.7480639524223353,0.7377450980392157,0.21414291381922468,['BIK'],0.7616960973411933,0,0,1
440,Regulation Of Autophagy (GO:0010506),0.7983492057799227,0.630672268907563,0.14203318202176338,['PLEKHF1'],0.811050215871876,0,0,1
441,Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),0.8092835293464885,0.6085192697768763,0.12876630086143867,['SFRP2'],0.8184383204024442,0,0,1
442,Positive Regulation Of Apoptotic Process (GO:0043065),0.8092835293464885,0.6085192697768763,0.12876630086143867,['SFRP2'],0.8184383204024442,0,0,1
443,Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),0.8196314682875389,0.587843137254902,0.11692227550145662,['NFATC2'],0.827032203892844,0,0,1
444,Cellular Response To Oxygen-Containing Compound (GO:1901701),0.8386909465516251,0.5503676470588236,0.09681682371583716,['NR4A3'],0.8443577772715686,0,0,1
445,Cellular Respiration (GO:0045333),0.8474598713743393,0.5333333333333333,0.08827295480499174,['NR4A3'],0.8512686797850104,0,0,1
446,Regulation Of Apoptotic Process (GO:0042981),0.9068989881916933,0.4962585034013605,0.0484964673259334,"['SFRP2', 'BIK']",0.9089323939948136,0,0,2
447,Negative Regulation Of Apoptotic Process (GO:0043066),0.9445725342006598,0.34094579008073816,0.019441683117321543,['MTRNR2L8'],0.9445725342006598,0,0,1
